Femme et Homme
- | Pays :
- Australia
- | Organes : -
- | Spécialités : -
Extrait
This is a Phase II pilot study evaluating the safety of a risk-adjusted outpatient-based approach to lymphoma salvage therapy with VGF (vinorelbine, gemcitabine and pegfilgrastim) and/or F-GIV (gemcitabine, Ifosfamide, vinorelbine and pegfilgrastim) in combination with Rituximab (R-VGF/R-F-GIV).
Critère d'inclusion
- Non-Hodgkin's Lymphoma (CD20+)